Patents by Inventor Christoph Bardorz

Christoph Bardorz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230173151
    Abstract: A medical device having a time-controlled start function and a control unit, which enables user-friendly operation of the medical device, is described. The medical device has a control unit, which is equipped for automatic start-up of the medical device at a predetermined point in time and for checking on whether, after start-up of the medical device, a predetermined event has occurred, and has a display screen for display of information when the check reveals that the event has not occurred. Furthermore, a corresponding process for user-friendly operation is described.
    Type: Application
    Filed: December 7, 2022
    Publication date: June 8, 2023
    Applicant: FRESENIUS MEDICAL CARE DEUTSCHLAND GMBH
    Inventors: Christoph BARDORZ, Matthias PFEUFFER, Thomas SCHMITT, Carsten MUELLER
  • Patent number: 11571500
    Abstract: A medical device having a time-controlled start function and a control unit, which enables user-friendly operation of the medical device, is described. The medical device has a control unit, which is equipped for automatic start-up of the medical device at a predetermined point in time and for checking on whether, after start-up of the medical device, a predetermined event has occurred, and has a display screen for display of information when the check reveals that the event has not occurred. Furthermore, a corresponding process for user-friendly operation is described.
    Type: Grant
    Filed: May 19, 2017
    Date of Patent: February 7, 2023
    Assignee: PRESENIUS MEDICAL CARE DEUTSCHLAND GMBH
    Inventors: Christoph Bardorz, Matthias Pfeuffer, Thomas Schmitt, Carsten Mueller
  • Patent number: 11305043
    Abstract: The present disclosure relates to a method and system for regulating and/or monitoring a heating device for heating a fluid, which has flowed in an in-flow section of a dialysis fluid circuit. The dialysis fluid circuit is part of a blood treatment apparatus, which comprises a container for receiving the fluid and a heating container for heating the fluid. The method encompasses the step of starting a heating process for heating the fluid in the heating container. The fluid is in fluid communication with the container when the filling level of the container reaches a pre-determined filling level value by means of direct or indirect flow from the inlet.
    Type: Grant
    Filed: January 27, 2017
    Date of Patent: April 19, 2022
    Assignee: Fresenius Medical Care Deutschland GmbH
    Inventors: Peter Klöffel, Helmuth Ender, Michael Schlereth, Christoph Bardorz, Walter Ehrenberger
  • Patent number: 11241524
    Abstract: The invention relates to a dialysis machine having an extracorporeal blood circuit in which a dialyzer, a blood pump, and an arterial pressure sensor are arranged, wherein the dialysis machine furthermore has a compensation device by means of which the set value for the blood flow through the extracorporeal circuit can be corrected to a compensated value using the arterial blood pressure; wherein the dialysis machine furthermore has recognition means which are configured to recognize whether the arterial pressure sensor is connected to the extracorporeal blood circuit or not; and wherein the dialysis machine has an estimator unit which is configured to estimate a value for the arterial blood pressure if it is recognized by the recognition means that the arterial pressure sensor is not connected to the extracorporeal blood circuit.
    Type: Grant
    Filed: July 19, 2017
    Date of Patent: February 8, 2022
    Assignee: FRESENIUS MEDICAL CARE DEUTSCHLAND GMBH
    Inventors: Wei Zhang, Christoph Bardorz
  • Publication number: 20210220502
    Abstract: A medical device having a time-controlled start function and a control unit, which enables user-friendly operation of the medical device, is described. The medical device has a control unit, which is equipped for automatic start-up of the medical device at a predetermined point in time and for checking on whether, after start-up of the medical device, a predetermined event has occurred, and has a display screen for display of information when the check reveals that the event has not occurred. Furthermore, a corresponding process for user-friendly operation is described.
    Type: Application
    Filed: May 19, 2017
    Publication date: July 22, 2021
    Applicant: FRESENIUS MEDICAL CARE DEUTSCHLAND GMBH
    Inventors: Christoph BARDORZ, Mathias PFEUFFER, Thomas SCHMITT, Carsten MUELLER
  • Publication number: 20210170086
    Abstract: The present disclosure relates to a method and system for regulating and/or monitoring a heating device for heating a fluid, which has flowed in an in-flow section of a dialysis fluid circuit. The dialysis fluid circuit is part of a blood treatment apparatus, which comprises a container for receiving the fluid and a heating container for heating the fluid. The method encompasses the step of starting a heating process for heating the fluid in the heating container. The fluid is in fluid communication with the container when the filling level of the container reaches a pre-determined filling level value by means of direct or indirect flow from the inlet.
    Type: Application
    Filed: January 27, 2017
    Publication date: June 10, 2021
    Inventors: Peter Klöffel, Helmuth Ender, Michael Schlereth, Christoph Bardorz, Walter Ehrenberger
  • Publication number: 20210001028
    Abstract: The present invention pertains to medical device (1), preferably a dialysis device for performing a hemodialysis, and/or hemofiltration and/or hemodiafiltration, comprising a first functional module (CPU1) and a second functional module (CPU2), wherein an operating hours counter (2) for counting the operating hours is provided in the first functional module (CPU1), and wherein the first functional module (CPU1) is configured to store an operating hours value determined by the operating hours counter (2) in the a first storage (M1) of the first functional module (CPU1), wherein a second storage (M2) is provided in the second functional module (CPU2), wherein the second functional module (CPU2) is configured to store the operating hours value determined by the operating hours counter (2) of the first functional module (CPU1) in the second storage (M2).
    Type: Application
    Filed: March 22, 2019
    Publication date: January 7, 2021
    Inventors: Christoph Bardorz, Jochen Siebert, Stefan Kellermann
  • Publication number: 20200075159
    Abstract: The present invention relates to an extracorporeal blood treatment device comprising at least one output unit for outputting at least one report to a user of the blood treatment device, wherein the blood treatment device is configured to output at least one report by means of the output device after the end of a specific period of time since the switching on of the blood treatment device and/or on the occurrence of a specific event, said report relating to one or more pieces of information relating to the validity of a test carried out at the blood treatment device.
    Type: Application
    Filed: November 3, 2017
    Publication date: March 5, 2020
    Applicant: FRESENIUS MEDICAL CARE DEUTSCHLAND GMBH
    Inventors: Christoph BARDORZ, Olaf NICHOLAS, Carsten MUELLER, Karin Helga TRAUNER
  • Publication number: 20190282748
    Abstract: The invention relates to a dialysis machine having an extracorporeal blood circuit in which a dialyzer, a blood pump, and an arterial pressure sensor are arranged, wherein the dialysis machine furthermore has a compensation device by means of which the set value for the blood flow through the extracorporeal circuit can be corrected to a compensated value using the arterial blood pressure; wherein the dialysis machine furthermore has recognition means which are configured to recognize whether the arterial pressure sensor is connected to the extracorporeal blood circuit or not; and wherein the dialysis machine has an estimator unit which is configured to estimate a value for the arterial blood pressure if it is recognized by the recognition means that the arterial pressure sensor is not connected to the extracorporeal blood circuit.
    Type: Application
    Filed: July 19, 2017
    Publication date: September 19, 2019
    Applicant: FRESENIUS MEDICAL CARE DEUTSCHLAND GMBH
    Inventors: Wei ZHANG, Christoph BARDORZ
  • Patent number: 9814412
    Abstract: A method and device for determining the concentration of blood constituents, in particular haemoglobin, in a hose line of an extracorporeal blood circuit of an extracorporeal blood treatment apparatus, and an extracorporeal blood treatment apparatus with a device for determining the concentration of a blood constituent, are based on the correction of the influence of the blood flow rate of the blood flowing through the hose line on the determination of the concentration of the blood constituent. The device comprises a computing and evaluation unit configured such that a correction factor is ascertained for the influence of the blood flow rate on the determination of the concentration of the blood constituent. The concentration of the blood constituent is then determined based on a relationship describing the dependence of the concentration of the blood constituent on the intensity of the decoupled electromagnetic radiation, taking account of the correction factor.
    Type: Grant
    Filed: November 26, 2012
    Date of Patent: November 14, 2017
    Assignee: Fresenius Medical Care Deutschland GmbH
    Inventors: Wei Zhang, Christoph Bardorz, Carsten Mueller, Elke Schulte
  • Patent number: 8858486
    Abstract: A method for determining the recirculation in a fistula and/or the cardiopulmonary recirculation part during an extracorporeal blood treatment is disclosed, where the blood to be treated flows in an extracorporeal blood circuit through a blood chamber of a dialyzer split by a semi-permeable membrane into the blood chamber and a liquid chamber, and dialysis liquid flows in a dialysis liquid path through the dialysis liquid chamber of the dialyzer. A device for determining the recirculation in a fistula and/or the cardiopulmonary recirculation part, and a blood treatment device including such a device are also disclosed. The method and device are based on the fact that the sum of the fistula recirculation and the cardiopulmonary recirculation part, i.e. the total recirculation, is determined for two blood flow rates which differ from each other. The fistula recirculation and/or the cardiopulmonary recirculation part are then determined from the recirculation for the two blood flow rates.
    Type: Grant
    Filed: November 22, 2008
    Date of Patent: October 14, 2014
    Assignee: Fresenius Medical Care Deutschland GmbH
    Inventors: Wei Zhang, Elke Schulte, Christoph Bardorz
  • Patent number: 8792089
    Abstract: A device for determining the concentration of a constituent of blood in a hose line, in particular in the hose line of an extracorporeal blood circuit of an extracorporeal blood treatment apparatus, includes a clamping unit having an actuation mechanism configured to apply a clamping force such that first and second receiving elements are moved towards one another from a first position releasing the hose line into a second position clamping the hose line, in which the drive of the actuation mechanism takes place with an electric motor, and a monitoring unit configured to detect a hose line inserted into the receiving elements. A method for detecting a hose line in a clamping unit of a device for determining the concentration of a blood constituent in the hose line is also described. Automation of the measurement of the blood parameters is thus possible.
    Type: Grant
    Filed: July 20, 2012
    Date of Patent: July 29, 2014
    Assignee: Fresenius Medical Care Deutschland GmbH
    Inventors: Wei Zhang, Elke Schulte, Martin Kaiser, Carsten Mueller, Tom Klein, Stefan Zerle, Christoph Bardorz, Stefan Stuehler
  • Publication number: 20130144139
    Abstract: A method and device for determining the concentration of blood constituents, in particular haemoglobin, in a hose line of an extracorporeal blood circuit of an extracorporeal blood treatment apparatus, and an extracorporeal blood treatment apparatus with a device for determining the concentration of a blood constituent, are based on the correction of the influence of the blood flow rate of the blood flowing through the hose line on the determination of the concentration of the blood constituent. The device comprises a computing and evaluation unit configured such that a correction factor is ascertained for the influence of the blood flow rate on the determination of the concentration of the blood constituent. The concentration of the blood constituent is then determined based on a relationship describing the dependence of the concentration of the blood constituent on the intensity of the decoupled electromagnetic radiation, taking account of the correction factor.
    Type: Application
    Filed: November 26, 2012
    Publication date: June 6, 2013
    Inventors: Wei Zhang, Christoph Bardorz, Carsten Mueller, Elke Schulte
  • Publication number: 20130033697
    Abstract: A device for determining the concentration of a constituent of blood in a hose line, in particular in the hose line of an extracorporeal blood circuit of an extracorporeal blood treatment apparatus, includes a clamping unit having an actuation mechanism configured to apply a clamping force such that first and second receiving elements are moved towards one another from a first position releasing the hose line into a second position clamping the hose line, in which the drive of the actuation mechanism takes place with an electric motor, and a monitoring unit configured to detect a hose line inserted into the receiving elements. A method for detecting a hose line in a clamping unit of a device for determining the concentration of a blood constituent in the hose line is also described. Automation of the measurement of the blood parameters is thus possible.
    Type: Application
    Filed: July 20, 2012
    Publication date: February 7, 2013
    Applicant: FRESENIUS MEDICAL CARE DEUTSCHLAND GMBH
    Inventors: Wei Zhang, Elke Schulte, Martin Kaiser, Carsten Mueller, Tom Klein, Stefan Zerle, Christoph Bardorz, Stefan Stuehler
  • Publication number: 20110004141
    Abstract: A method for determining the recirculation in a fistula and/or the cardiopulmonary recirculation part during an extracorporeal blood treatment is disclosed, where the blood to be treated flows in an extracorporeal blood circuit through a blood chamber of a dialyzer split by a semi-permeable membrane into the blood chamber and a liquid chamber, and dialysis liquid flows in a dialysis liquid path through the dialysis liquid chamber of the dialyzer. A device for determining the recirculation in a fistula and/or the cardio-pulmonary recirculation part, and a blood treatment device including such a device are also disclosed. The method and device are based on the fact that the sum of the fistula recirculation and the cardiopulmonary recirculation part, i.e. the total recirculation, is determined for two blood flow rates which differ from each other. The fistula recirculation and/or the cardiopulmonary recirculation part are then determined from the recirculation for the two blood flow rates.
    Type: Application
    Filed: November 22, 2007
    Publication date: January 6, 2011
    Inventors: Wei Zhang, Elke Schulte, Christoph Bardorz
  • Patent number: 7131957
    Abstract: A device and method for increasing the safety of an extracorporeal blood treatment machine are based on monitoring transmembrane pressure. The transmembrane pressure measured by a measuring device during the treatment is compared with an upper limit transmembrane pressure L1 and a lower limit transmembrane pressure L2 which define a monitoring window. If the transmembrane pressure is outside this monitoring window, an alarm is triggered by an alarm device. The monitoring window is shifted as a function of the ultrafiltration rate. To determine the window limits, the transmembrane pressure is established after a change in the ultrafiltration rate is calculated. Thereafter, the window limits are determined on the basis of the expected transmembrane pressure.
    Type: Grant
    Filed: June 3, 2004
    Date of Patent: November 7, 2006
    Assignee: Fresenius Medical Care Deutschland GmbH
    Inventors: Carsten Müller, Christoph Bardorz
  • Patent number: 6860866
    Abstract: A method and a device for determining the efficiency of a dialyzer of a dialysis machine during a dialysis treatment wherein the dialyzer is divided by a semipermeable membrane into a blood chamber and a dialysis fluid chamber and wherein the blood flows at a predetermined flow rate through the blood chamber and dialysis fluid flows at a predetermined flow rate through the dialysis fluid chamber. In use, the dialysance or clearance for a predetermined dialysis fluid flow rate and/or blood flow rate is measured, and then the dialysance or clearance for any dialysis fluid flow rate and blood flow rate is calculated.
    Type: Grant
    Filed: June 22, 2000
    Date of Patent: March 1, 2005
    Assignee: Fresenius Medical Care Deutschland GmbH
    Inventors: Thomas Graf, Christoph Bardorz, Malte Gross, Rainer Goldau
  • Publication number: 20040217056
    Abstract: A device and method for increasing the safety of an extracorporeal blood treatment machine are based on monitoring transmembrane pressure. The transmembrane pressure measured by a measuring device during the treatment is compared with an upper limit transmembrane pressure L1 and a lower limit transmembrane pressure L2 which define a monitoring window. If the transmembrane pressure is outside this monitoring window, an alarm is triggered by an alarm device. The monitoring window is shifted as a function of the ultrafiltration rate. To determine the window limits, the transmembrane pressure is established after a change in the ultrafiltration rate is calculated. Thereafter, the window limits are determined on the basis of the expected transmembrane pressure.
    Type: Application
    Filed: June 3, 2004
    Publication date: November 4, 2004
    Inventors: Carsten Muller, Christoph Bardorz
  • Patent number: 6767333
    Abstract: A device and method for increasing the safety of an extracorporeal blood treatment machine are based on monitoring transmembrane pressure. The transmembrane pressure measured by a measuring device during the treatment is compared with an upper limit transmembrane pressure L1 and a lower limit transmembrane pressure L2 which define a monitoring window. If the transmembrane pressure is outside this monitoring window, an alarm is triggered by an alarm device. The monitoring window is shifted as a function of the ultrafiltration rate. To determine the window limits, the transmembrane pressure is established after a change in the ultrafiltration rate is calculated. Thereafter, the window limits are determined on the basis of the expected transmembrane pressure.
    Type: Grant
    Filed: August 28, 2000
    Date of Patent: July 27, 2004
    Assignee: Fresenius Medical Care Deutschland
    Inventors: Carsten Müller, Christoph Bardorz